Parameter | All (n = 59) | Non-randomized (n = 27) | NaCl (n = 15) | NaCl/Na-acetate (n = 17) |
---|---|---|---|---|
Age | 53.4 + 13.4 | 53.2 + 14.1 | 56.3 + 13.4 | 51.4 + 13.7 |
Gender (% female) | 76.3% [64.3–85.7] | 59.2% [40.6–76.1] | 80% [55.6–94] | 100% |
H&H 1–2 | 44.1% [31.2–57.6] | 66.7% [46.0–83.5] | 20.0% [6.0–44.4] | 29.4% [12.2–53.0] |
H&H 3 | 39.0% [26.5–52.6] | 29.6% [15.1–48.2] | 66.7% [41.6–86.0] | 29.4% [12.2–53.0] |
H&H 4 | 15.3% [7.8–26.0] | 3.7% [0.4–16.0] | 13.3% [2.9–36.3] | 35.3% [16.3–58.9] |
H&H 5 | 1.7% [0.2–7.6] | 0% | 5.9% [0.6–24.4] | |
GCS on admit (median + IQR) | 14 [11–15] | 15 [13.5–15] | 14 [7–15] | 13 [7–15] |
SOFA score on admit (median ± IQR) | 1 [0–3] | 1 [0–2] | 2 [1–4.5] | 2 [1–3] |
HTN | 47.5% [34.3–60.9] | 40.7% [23.9–59.4] | 53.3% [29.4–76.1] | 52.9% [30.3–74.6] |
CAD | 6.8% [1.9–16.5] | 3.7% [0.4–16.0] | 13.3% [2.9–36.3] | 5.9% [0.6–24.4] |
DM | 11.9% [4.9–22.9] | 11.1% [3.2–26.8] | 13.3% [2.9–36.3] | 11.8% [2.5–32.7] |
Smoker | 47.5% [34.3–60.9] | 55.6% [37.1–72.9] | 40.0% [18.8–64.7] | 41.2% [20.7–64.4] |
CKD | 1.7% [0.0–9.1] | 0% | 6.7% [0.7–27.2] | 0% |
EtOH abuse | 10.2% [3.8–20.8] | 14.8% [5.2–31.5] | 6.7% [0.7–27.2] | 5.9% [0.6–24.4] |
Illicit drug use | 25.4% [15.0–38.4] | 29.6% [15.1–48.2] | 6.7% [0.7–27.2] | 35.3% [16.3–58.9] |
First creatinine (mean ± SD) | 0.80 + 0.31 | 0.82 + 0.27 | 0.79 + 0.26 | 0.76 + 0.42 |
Surgical approach to the aneurysm (% treated with endovascular approach) | 69.5% [57..0–80.1] | 81.5% [64.1–92.6] | 66.7% [41.6–86.0] | 52.9% [30.3–74.6] |